Market Tracker

10/31 6:00pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

During the Trading Day
9.75 +0.23 / +2.42%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.75 +0.0012 / +0.01%
 
Volume: 19.1K
Taken by Surprise
4:26pm / TheStreet.com
Sitting Tight With My Longs
10:50am / TheStreet.com

Today’s Trading

Previous close9.52
Today’s open9.73
Day’s range9.65 - 9.85
Volume587,391
Average volume (3 months)501,704
Market cap$362.2M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)+20.71%
Earnings growth (next 5 years)+3.90%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book3.20

Competitors

 Today’s
change
Today’s
% change
TKMRTekmira Pharmaceutic...-0.26-1.53%
CORTCorcept Therapeutics...-0.21-6.07%
TKAITokai Pharmaceutical...-0.17-1.09%
VVUSVIVUS Inc+0.04+1.04%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 18, 2014
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts